40 results on '"Andersson, Fredrik L"'
Search Results
2. Clostridioides difficile infection, recurrence and the associated healthcare consumption in Sweden between 2006 and 2019: a population-based cohort study
3. Epidemiological and clinical burden of Clostridioides difficile infections and recurrences between 2015 − 2019: the RECUR Germany study
4. Nocturnal polyuria in women: results from the EpiNP study
5. Estimating excess mortality and economic burden of Clostridioides difficile infections and recurrences during 2015-2019: The RECUR England study
6. Unmet Parenthood Goals, Health-Related Quality of Life and Apparent Irrationality: Understanding the Value of Treatments for Infertility
7. Clostridioides difficile infections, recurrences, and clinical outcomes in real-world settings from 2015 to 2019: The RECUR England study
8. Clostridioides difficile infection-associated cause-specific and all-cause mortality: a population-based cohort study
9. Psychometric validation and interpretation of the Nocturia Impact Diary in a clinical trial setting
10. The Prevalence of Nocturnal Polyuria in the United States: Results from the Epidemiology of Nocturnal Polyuria Study
11. The combined effect of systemic antibiotics and proton pump inhibitors on Clostridioides difficile infection and recurrence
12. Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI
13. Annual direct and indirect costs attributable to nocturia in Germany, Sweden, and the UK
14. The patient burden of nocturnal polyuria in the United States: Results from the epidemiology of nocturnal polyuria (EpiNP) study
15. Differences in the Prevalence of Nocturnal Polyuria in the U.S. by Definition: Results From the Epidemiology of Nocturnal Polyuria Study. Reply.
16. Partially different? The importance of general equilibrium in health economic evaluations: An application to nocturia
17. Non‐invasive monitoring and treat‐to‐target approach are cost‐effective in patients with mild–moderate ulcerative colitis
18. Patients’ Lived Experiences of Nocturia: A Qualitative Study of the Evening, the Night, and the Next Day
19. Nocturia Work Productivity and Activity Impairment Compared with Other Common Chronic Diseases
20. Differences in the Prevalence of Nocturnal Polyuria in the U.S. by Definition: Results from the Epidemiology of Nocturnal Polyuria Study
21. Non‐invasive monitoring and treat‐to‐target approach are cost‐effective in patients with mild–moderate ulcerative colitis.
22. Partially different? The importance of general equilibrium in health economic evaluations: An application to nocturia.
23. Cost-effectiveness analysis of carbetocin versus oxytocin for the prevention of postpartum hemorrhage following vaginal birth in the United Kingdom
24. Psychometric validation and interpretation of the Nocturia Impact Diary in a clinical trial setting
25. MP08-19 COMORBID CONDITIONS ASSOCIATED WITH NOCTURNAL POLYURIA: RESULTS FROM THE EPIDEMIOLOGY OF NOCTURNAL POLYURIA (EpiNP) STUDY
26. Additional file 1 of Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI
27. Psychometric evaluation of the Nocturia Sleep Quality Scale based on data from a prospective observational study
28. The Impact of Atrial Fibrillation on the Cost of Stroke: The Berlin Acute Stroke Study
29. Achieving clinically meaningful quality of life benefits in nocturia takes time: Results from a long‐term, multicenter phase 3 study of desmopressin in Japanese patients
30. Assessing the burden of nocturia in the workplace: the associations between nocturnal voiding, subjective well-being, work engagement and productivity
31. Resource utilization and costs in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme
32. Cost-effectiveness of early intervention with once-daily budesonide in children with mild persistent asthma: results from the START study
33. Are Cost Benefits of Anticoagulation for Stroke Prevention in Atrial Fibrillation Underestimated?
34. Impact of nocturia on patients' health‐related quality of life and healthcare resource utilisation compared with OAB and BPH: Results from an observational survey in European and American patients
35. Development of the Nocturia Sleep Quality Scale: a patient-reported outcome measure of sleep impact related to nocturia
36. Nocturia Sleep Quality Scale
37. Achieving clinically meaningful quality of life benefits in nocturia takes time: Results from a long‐term, multicenter phase 3 study of desmopressin in Japanese patients.
38. Nocturia is more bothersome than daytime LUTS: Results from an Observational, Real-life Practice Database including 8659 European and American LUTS patients
39. Annual direct and indirect costs attributable to nocturia in Germany, Sweden, and the UK
40. Hospital use for COPD patients during the last few years of their life
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.